Tekmira Pharmaceuticals this week said that the underwriters of its recent public stock offering of 3.75 million shares have exercised their over-allotment option to buy an additional 562,000 shares at $8 apiece.
With the additional stock sold, Tekmira raised a total of about $34.5 million in the transaction.